Navigation

🏠 Home 📰 Latest News 🌍 World 🇮🇳 India 💼 Business 💻 Technology ⚽ Sports 🎬 Entertainment 🏥 Health
Biggest News Aggregation in the World
📰 Eisai Patient Support Program News

Eisai Patient Support Program News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Eisai Patient Support Program. Real-time updates on events, politics, business and more.

BioArctic: FDA approves LEQEMBI (lecanemab-irmb) under the Accelerated Approval pathway for the treatment of Alzheimer's disease

January 9, 2023
STOCKHOLM, Jan. 9, 2023 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that under the Accelerated Approval pathway the U.S. Food and Drug Administration
Uppsala Lan Oskar Bosson Gunilla Osswald Uppsala University Vp Communications Eisai Patient Support Program
Source: finanznachrichten.de

Eisai : FDA Approves LEQEMBI™ (lecanemab-irmb) Under the Accelerated Approval Pathway for the Treatment of Alzheimer's DiseaseAccelerated Approval is based on Phase 2 data showing a reduction in amyloid-beta plaques in early AD patients treated with LEQEMBI™ Treatment with LEQEMBI should be initiated in patients with mild cognitive impairment or mild dementia stage of disease, the population in which treatment was initiated in clinical trials

January 6, 2023
FDA Approves LEQEMBI™ Under the Accelerated Approval Pathway for the Treatment of Alzheimers Disease Accelerated Approval is based... | January 6, 2023
United Kingdom New Zealand United States Haruo Naito Christophera Viehbacher Natacha Gassenbach
Source: marketscreener.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science